BOTOXChronicMigraine. com
DON’ T LIE DOWN
STAND UP
TO CHRONIC MIGRAINE
For adults with Chronic Migraine
For adults with Chronic Migraine, 15 or more headache days a month, each lasting 4 hours or more
BOTOX ® prevents on average 8 to 9 headache days and migraine / probable migraine days a month( versus 6 to 7 for placebo). BOTOX ® is not approved for adults with migraine who have 14 or fewer headache days a month.
Talk to a headache specialist Go online for more information and to learn about savings
BOTOX ® is the first and only FDA-approved preventive treatment for Chronic Migraine
● BOTOX ® is proven to prevent headaches before they even start
● BOTOX ® is shown to prevent migraines before they even start
● BOTOX ® is injected by a doctor once every 12 weeks
● BOTOX ® is covered by most insurance companies
BOTOXChronicMigraine. com
INDICATION
BOTOX ® is a prescription medicine that is injected to prevent headaches in adults with chronic migraine who have 15 or more days each month with headache lasting 4 or more hours each day in people 18 years or older.
It is not known whether BOTOX ® is safe or effective to prevent headaches in patients with migraine who have 14 or fewer headache days each month( episodic migraine).
IMPORTANT SAFETY INFORMATION
BOTOX ® may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time( hours to weeks) after injection of BOTOX ®:
● Problems swallowing, speaking, or breathing, due to weakening of associated muscles, can be severe and result in loss of life. You are at the highest risk if these problems are pre-existing before injection. Swallowing problems may last for several months.
Please see additional Important Safety Information on adjacent page.
● Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms including: loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, trouble swallowing.
© 2016 Allergan, Inc., Irvine, CA 92612. ® marks owned by Allergan, Inc. Dysport is a registered trademark of Ipsen Biopharm Limited Company. Myobloc is a registered trademark of Solstice Neurosciences, Inc. Xeomin is a registered trademark of Merz Pharma GmbH & Co KGaA. APC24HN16
12 HeadWise ® | Volume 6, Issue 2 • 2016